Lin, C.-C.; Cheng, K.-P.; Hung, H.-C.; Li, C.-H.; Lin, C.-H.; Chang, C.-J.; Hu, C.-Y.; Wu, H.-T.; Ou, H.-Y.
Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels. J. Clin. Med. 2019, 8, 1436.
https://doi.org/10.3390/jcm8091436
AMA Style
Lin C-C, Cheng K-P, Hung H-C, Li C-H, Lin C-H, Chang C-J, Hu C-Y, Wu H-T, Ou H-Y.
Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels. Journal of Clinical Medicine. 2019; 8(9):1436.
https://doi.org/10.3390/jcm8091436
Chicago/Turabian Style
Lin, Chun-Chung, Kai-Pi Cheng, Hao-Chang Hung, Chung-Hao Li, Ching-Han Lin, Chih-Jen Chang, Che-Yuan Hu, Hung-Tsung Wu, and Horng-Yih Ou.
2019. "Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels" Journal of Clinical Medicine 8, no. 9: 1436.
https://doi.org/10.3390/jcm8091436
APA Style
Lin, C.-C., Cheng, K.-P., Hung, H.-C., Li, C.-H., Lin, C.-H., Chang, C.-J., Hu, C.-Y., Wu, H.-T., & Ou, H.-Y.
(2019). Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels. Journal of Clinical Medicine, 8(9), 1436.
https://doi.org/10.3390/jcm8091436